Results 51 to 60 of about 103,300,016 (308)

Flow Chart of Follow Up and Loss to Follow Up.

, 2015
Flow Chart of Follow Up and Loss to Follow Up.
Glenda Gray (64254), Rachel Jewkes (193649), Kristin Dunkle (315117), Nwabisa Jama-Shai (713551)   +3 more
core   +1 more source

Factors of Loss to Follow-up Antiretroviral Therapy in Islanded Area

Unnes Journal of Public Health, 2018
Loss to follow-up of antiretroviral therapy is when PLWHA (People Living with HIV/AIDS) do not come for antiretroviral therapy for more than 3 months. This study aimed to determine the factors of loss to follow-up antiretroviral therapy for PLWHA at Prof.
Thomas Laga Boro, Rafael Paun, Marthen R Pellokila   +2 more
doaj   +1 more source

Optimal Follow-Up Duration for Assessment of Birth Defects After In Vitro Fertilization–Embryo Transfer: A Multicenter 5-Year Cohort Study in China

Frontiers in Endocrinology, 2022
ObjectiveTo investigate the impact of a 5-year follow-up on the incidence of identified birth defects in children conceived using assisted reproductive technologies (ART).MethodsA 5-year cohort study was performed in three ART centers from January 2013 ...
Chun-Lin Liu, Ping Li, Gui-Feng Cai, Abraham Morse, Abraham Morse, Jun Liu, Zhi-Heng Chen, Xiu Zhang, Ling Sun   +8 more
doaj   +1 more source

Management of asthma in Benin: the challenge of loss to follow-up [PDF]

Public Health Action, 2013
SETTING: An asthma pilot project in Benin.OBJECTIVE: To assess the implementation of standard case management of asthma at three referral centres and three primary care centres.METHODS: The project began with local adaptation of international asthma guidelines, followed by situation analysis, pre-intervention, training and intervention.
G, Ade, M, Gninafon, L, Tawo, N, Aït-Khaled, D A, Enarson, C-Y, Chiang   +5 more
openaire   +2 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari, Regina Hadi Putri, Fatimah Assyifa, Judith Spijkerman, Gertjan Johannes Kaspers, Susi Susanah   +5 more
wiley   +1 more source

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis [PDF]

, 2009
BACKGROUND: The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resource-limited settings. Loss to follow up can be substantial, but it is unclear what the outcomes are in patients who are lost to programmes ...
Matthias Egger, Egger, Matthias, Martin W G Brinkhof, Brinkhof Martin W. G., Egger Matthias, Pujades-Rodriguez, Mar, Brinkhof, M, Brinkhof, MW, Pujades-Rodriguez Mar, Mar Pujades-Rodriguez, Brinkhof, Martin W G, Martin W. G. Brinkhof, Pujades-Rodriguez, M, Egger, M, Pujades-Rodriguez M, Egger M, Brinkhof MW   +16 more
core   +3 more sources

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad, Ohad Atia, Osama Tanous, Dafna Brik Simon, Michal Dvori, Miriam Cohen, Tracie A. Goldberg, Efraim Bilavsky, Joanne Yacobovich, Orna Steinberg‐Shemer   +9 more
wiley   +1 more source

Retention in Care and Health Outcomes of HIV-Exposed Infants in a Prevention of Mother-to-Child Transmission of HIV (PMTCT) Cohort in Addis Ababa, Ethiopia

HIV/AIDS: Research and Palliative Care, 2021
Andamlak Gizaw Alamdo,1 Elizabeth J King2 1Department of Public Health, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia; 2Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann
Alamdo AG, King EJ
doaj  

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda

BMC Public Health, 2020
Background In 2018, Uganda started only 65% of persons with incident tuberculosis on treatment. Pretreatment loss to follow up is an important contributor to suboptimal treatment coverage.
Stella Zawedde-Muyanja, Achilles Katamba, Adithya Cattamanchi, Barbara Castelnuovo, Yukari C. Manabe   +4 more
doaj   +1 more source